Progress of diagnosis and treatment of intrahepatic cholangiocarcinoma
10.3760/cma.j.issn.1673-4203.2020.02.009
- VernacularTitle: 肝内胆管细胞癌的诊疗进展
- Author:
Keda SONG
1
;
Zihao LI
1
;
Hongchi JIANG
1
Author Information
1. Department of Liver Surgery, the First Affiliated Hospital, Harbin Medical University, Harbin 150001, China
- Publication Type:Review
- Keywords:
Bile duct neoplasms;
Diagnosis;
Therapeutic uses;
Intrahepatic cholangiocarcinoma
- From:
International Journal of Surgery
2020;47(2):112-117
- CountryChina
- Language:Chinese
-
Abstract:
Intrahepatic cholangiocarcinoma (ICC) is the second prevalent primary liver cancer, next to hepatocellular carcinoma. Epidemiologic studies suggest the morbidity of ICC is on the rise worldwide. Owing to the complex etiology, lack of effective screening methods, the concealment of early clinical symptoms and the limited treatment strategy, it is tough to diagnose to ICC and difficult for further treatment. In recent years, with the development of medical technology and the progress of medical treatment idea, active explorations have been made on the early diagnosis and treatment strategies of ICC. The aim of this narrative review is to summarize the research status relating to diagnostic methods and treatment strategies.
